LRVHealth

LRVHealth is a Boston-based venture capital firm established in 2000, focusing on early-stage investments primarily in the healthcare and technology sectors. The firm targets a range of investments from seed stage to Series B rounds, with a specific interest in software, telecommunications, medical devices, diagnostics, biotechnology, and healthcare technology-enabled services. In addition to healthcare, LRVHealth also invests in wireless technology, Internet infrastructure, and computer hardware and software. The firm typically invests between $0.5 million and $5 million in companies, often preferring to co-invest and exit through trade sales. LRVHealth's unique network of investors includes prominent healthcare providers, payers, and vendors, which strengthens its capacity to identify and support innovative healthcare solutions that address pressing industry challenges. Its operations extend beyond Boston to regions in Massachusetts, including Marlborough, Amherst, Northampton, and Springfield.

Yoola Adeniji

Associate

Will Cowen

General Partner

Lise Courtney D'Amico

Senior Associate

Christiana DelloRusso

Partner

Keith Figlioli

Managing Partner

Josh Flum

Managing Partner

Ellen Herlacher

Principal

John Kole

Venture Partner

Tripp Peake

Co-Founder and Managing Partner

87 past transactions

Hellocare

Venture Round in 2025
Hellocare is a telehealth platform that offers a comprehensive virtual healthcare delivery system, integrating software, hardware, and artificial intelligence. The platform facilitates various services, including home care, primary care, virtual patient observation, and remote patient monitoring. It also provides remote examination kits, telemedicine carts, and tools for alerting, communications, and workflow management. By leveraging this technology, healthcare providers can deliver medical services from any location, enhancing accessibility and efficiency in patient care.

LucyRx

Seed Round in 2025
LucyRx is an independent, next-generation pharmacy benefit manager (PBM) that is transforming prescription care.

Lumata Health

Series B in 2025
Lumata Health is a technology-driven healthcare startup dedicated to preventing blindness caused by chronic eye conditions. Founded in 2017 by Dr. Stephen R. Fransen, an experienced ophthalmologist and retina specialist, the company manages thousands of at-risk patients across the United States. Lumata Health employs a human-led care coordination and management platform that is generally free for patients. The firm collaborates with physicians, payers, and health systems to deliver comprehensive care management services, leveraging advanced technology and data science. It focuses on improving clinical outcomes, enhancing patient satisfaction, and increasing clinic staff efficiency through between-visit patient support and care coordination. Lumata Health addresses treatment adherence challenges associated with conditions such as diabetic retinopathy, macular degeneration, glaucoma, and dry eye, acting as a remote extension of in-clinic staff to facilitate recovery and better health outcomes for patients.

Proximity

Seed Round in 2025
Proximity is a company that offers an automation platform aimed at improving revenue from the 340B drug discount program for eligible healthcare providers. The platform is designed to streamline processes and enhance efficiency, ultimately helping healthcare organizations maximize their benefits from this federal program intended to support safety-net providers in delivering affordable medications to underserved populations.

Sware

Series B in 2024
Sware offers a validation automation platform and managed services that focus on helping companies ensure compliance with both domestic and international regulatory requirements. The company develops enterprise-wide software that automates compliance processes, encompassing a range of services such as quality management implementation, risk management, auditing, training, and computer systems validation. By implementing these systems and utilizing an integrated compliance ecosystem methodology, Sware enables its clients to achieve greater product efficiency and reduce costs.

Huddle Up

Series C in 2024
Huddle Up is a pediatric digital health company dedicated to supporting the growth, development, and mental health of children. Founded in 2015 and based in Madison, Wisconsin, Huddle Up transforms the care experience by emphasizing peer-to-peer interactions and specialty support. The company partners with school districts to promote academic performance and facilitate social-emotional development, while also focusing on community, equity, inclusion, and belonging. Through its personalized, outcome-driven approach, Huddle Up aims to enhance the well-being of children and adolescents, fostering healthier lives.

Greater Good Health

Series A in 2023
Greater Good Health is a healthcare organization focused on increasing access to value-based, holistic primary care, particularly in underserved and rural communities. Utilizing a Nurse Practitioner-led model, the organization collaborates with health plans to establish primary care practices and partners with risk-bearing organizations to implement private-labeled clinical programs. These initiatives aim to facilitate a transition to outcomes-focused care while enhancing patient experience. Greater Good Health's platform provides nurse practitioners with essential resources and tools to deliver quality, whole-person care, ultimately benefiting patients, providers, and payers alike by improving health outcomes and reducing overall costs.

Diana Health

Series B in 2023
Diana Health operates a network of contemporary women's health practices designed to enhance the delivery of maternity and women’s healthcare in collaboration with hospitals. The organization focuses on empowering women by offering personalized and comprehensive care that prioritizes their involvement in decision-making. Through an individualized care program, Diana Health integrates clinical care, education, and wellness support, all facilitated by a user-friendly technology platform. This approach aims to improve clinical outcomes and streamline operations, ultimately helping women prepare for childbirth and their parenting journeys.

Cortica

Series D in 2023
Cortica Inc. is a company dedicated to providing neurological therapies for children facing autism and other neurodevelopmental challenges. Founded in 2014 and based in San Diego, California, Cortica offers tailored treatment programs that are informed by a comprehensive understanding of each child's neurobiology and developmental profile. The company operates multiple centers across California, including locations in Carlsbad, Irvine, San Rafael, Torrance, and Westlake Village. Cortica's services encompass a wide range of assessments and therapies, including diagnoses for autism, ADHD, and developmental delays. Treatment options available include gene sequencing, metabolic testing, electroencephalography, nutrition evaluation, medication management, and various therapeutic interventions such as ABA therapy, parent coaching, speech-language therapy, occupational therapy, physical therapy, and music therapy. The company provides these services through in-home, in-clinic, and telehealth modalities.

Cortica

Series D in 2023
Cortica Inc. is an Israeli company established in 2007, specializing in advanced image understanding solutions through its proprietary AI technology. The company has developed its Image2Text technology, which enables computers to comprehend images and automatically generate contextual inventory from images and videos. This innovative approach allows Cortica's technology to extract and identify various concepts, including products, brands, and locations, mapping them to relevant keywords and taxonomies. Cortica's unique self-learning capabilities, supported by over 200 patents, enable it to achieve human-level image understanding, surpassing the capabilities of major tech companies. Its technology has applications across multiple industries, including autonomous vehicles, smart city initiatives, security, media, and medical analysis. By focusing on creating a "universal visual index of the world," Cortica aims to establish itself as a leader in the AI market for computer vision, embedding its capabilities into future platforms where image comprehension is essential. The company is headquartered in New York, with a significant research and development presence in Israel.

RxLightning

Series A in 2023
RxLightning is a digital platform focused on improving access to specialty medications by automating and streamlining the enrollment process. The company addresses the complexities associated with starting patients on specialty therapies across various fields, including addiction medicine, cardiology, endocrinology, and dermatology. By digitizing manual procedures, RxLightning reduces the burden of paperwork and enhances communication among healthcare providers, ultimately accelerating patients' speed to therapy. This innovative approach allows for a more efficient and effective management of specialty prescriptions, benefiting both healthcare professionals and patients alike.

Censinet

Venture Round in 2023
Censinet, Inc. is a healthcare-focused SaaS company that offers a cloud-based platform for managing third-party risk assessments. Founded in 2017 and based in Winchester, Massachusetts, Censinet connects healthcare providers with their vendors, streamlining the process of assessing and managing risks in real time. The platform eliminates the need for inefficient spreadsheets and manual workflows by automating risk assessments and providing continuous insights into vendor profiles. This approach enables healthcare organizations to identify and address potential threats within their vendor ecosystem effectively, enhancing overall cybersecurity and operational efficiency.

Upfront Healthcare Services

Series C in 2022
Upfront Healthcare Services, Inc. is a Chicago-based company that specializes in creating a data analytics platform aimed at enhancing the ambulatory care experience for patients and healthcare providers. Founded in 2015, the company focuses on automating and personalizing care navigation to improve patient engagement and optimize resource allocation within physician practices. Its platform, known as Care Traffic Control, utilizes advanced analytics and personalized content to guide patients to the most appropriate care options, thereby increasing appointment efficiency and improving clinical outcomes. By leveraging a variety of data sources—including demographics, billing, scheduling, claims, and care gaps—Upfront Healthcare Services ensures that patient needs are effectively matched with available healthcare resources.

KeyCare

Series A in 2022
KeyCare is a virtual care platform that leverages the Epic system to support health systems in enhancing patient access and quality of care. The platform is designed to provide a tech-driven virtual care team that supplements existing healthcare workforces, thereby broadening the options available for virtual care. By focusing on increasing accessibility and improving care quality, KeyCare aims to meet the needs of patients and healthcare providers in a rapidly evolving healthcare landscape.

Cleerly

Series C in 2022
Cleerly is a healthcare company focused on improving the prevention of heart attacks through innovative digital care pathways. It aims to establish a new standard for coronary artery disease by combining advanced clinical science with cutting-edge artificial intelligence. Cleerly's platform offers a non-invasive approach that quantifies and characterizes plaque buildup in coronary arteries, enhancing the understanding of cardiovascular health. By providing actionable clinical insights, the company enables healthcare providers to better identify at-risk patients and implement early treatment strategies. Ultimately, Cleerly's data-driven solutions aspire to deliver significant value to the healthcare system while improving heart health outcomes for individuals susceptible to heart attacks.

Socially Determined

Series B in 2022
Socially Determined, Inc. develops a risk intelligence platform focused on social determinants of health (SDOH). Its primary offering, SocialScape, provides insights into social risks through a combination of social risk indices and visualizations derived from diverse data sources. This platform enables organizations, including health plans, providers, life science companies, and government agencies, to understand the dynamics of social risk and implement actionable programs aimed at enhancing health outcomes while reducing costs. Founded in 2017 and headquartered in Washington, D.C., Socially Determined utilizes secure, cloud-based technology to analyze and visualize community and individual SDOH risks, allowing clients to tailor their intervention strategies to address the specific needs of socially and clinically complex patients.

Greater Good Health

Series A in 2022
Greater Good Health is a healthcare organization focused on increasing access to value-based, holistic primary care, particularly in underserved and rural communities. Utilizing a Nurse Practitioner-led model, the organization collaborates with health plans to establish primary care practices and partners with risk-bearing organizations to implement private-labeled clinical programs. These initiatives aim to facilitate a transition to outcomes-focused care while enhancing patient experience. Greater Good Health's platform provides nurse practitioners with essential resources and tools to deliver quality, whole-person care, ultimately benefiting patients, providers, and payers alike by improving health outcomes and reducing overall costs.

Season Health

Series A in 2022
Season is a platform that offers personalized nutrition planning for consumers. It integrates technology with advice from users' registered dietitians to help them get more out of their nutrition and make the most out of mealtime every day. The platform recommends what to eat for breakfast, lunch, and dinner based on nutritional needs, food preferences, and budget.

Activ Surgical

Series B in 2022
Activ Surgical Inc. is a digital surgery company based in Boston, Massachusetts, focused on enhancing surgical efficiency, accuracy, and patient outcomes through advanced technology. Founded in 2014, the company has developed a robotic surgery platform that integrates computer vision, artificial intelligence, and robotics to assist surgeons during complex procedures. One of its key products is the Smart Tissue Autonomous Robot (STAR), which aims to revolutionize surgical practices by improving intraoperative decision-making and reducing the risk of unintended surgical complications. The platform is scalable and patent-protected, designed to support surgeons with augmented reality and data-driven insights, ultimately making surgeries safer and more effective.

Burns & Levinson

Series A in 2022
Burns & Levinson is a full-service law firm based in Boston, Massachusetts, established in 1960. The firm offers a wide range of legal services to regional, national, and international clients, focusing on areas such as business and finance, business litigation, family law, venture capital, employment, estate planning, intellectual property, private equity, and real estate. With expertise in corporate law and various sectors including automotive, cannabis, media, energy, clean-tech, industrials, life sciences, and sports, Burns & Levinson is committed to delivering client-centered, results-oriented solutions. The firm also provides services related to government investigations, white-collar criminal defense, tax, bankruptcy, lending and leasing, design and construction, and environmental law.

Story Health

Series A in 2022
Story Health Corporation, founded in 2020 and based in Saratoga, California, develops advanced virtualized clinical care software tools aimed at aiding healthcare specialists, particularly neurologists and primary care physicians. The company offers a comprehensive healthcare technology platform that includes virtual patient programs, therapy management, and analytics designed to bridge the gap between clinical evidence and patient experiences. By utilizing data from high-frequency sources, Story Health empowers clinicians to better understand medical situations and make informed decisions regarding the physiological impacts of diseases and therapies. Through its innovative approach, Story Health enhances the ability of specialists to deliver effective patient care.

Sware

Series A in 2022
Sware offers a validation automation platform and managed services that focus on helping companies ensure compliance with both domestic and international regulatory requirements. The company develops enterprise-wide software that automates compliance processes, encompassing a range of services such as quality management implementation, risk management, auditing, training, and computer systems validation. By implementing these systems and utilizing an integrated compliance ecosystem methodology, Sware enables its clients to achieve greater product efficiency and reduce costs.

Reimagine Care

Series A in 2022
Reimagine Care is a healthcare company focused on enhancing community-based oncology care through technology-enabled services. Established in 2020 and based in Nashville, Tennessee, the company seeks to improve the affordability, accessibility, and patient-centricity of cancer care. By collaborating with healthcare systems and independent oncology practices, Reimagine Care supports value-based oncology care delivery. Their approach involves providing the necessary personnel, processes, and a comprehensive technology platform that facilitates the effective and scalable delivery of high-quality cancer care at various locations, including patients' homes. This model aims to enable patients to receive treatment and supportive care in a more convenient and cost-effective manner.

Diana Health

Series A in 2022
Diana Health operates a network of contemporary women's health practices designed to enhance the delivery of maternity and women’s healthcare in collaboration with hospitals. The organization focuses on empowering women by offering personalized and comprehensive care that prioritizes their involvement in decision-making. Through an individualized care program, Diana Health integrates clinical care, education, and wellness support, all facilitated by a user-friendly technology platform. This approach aims to improve clinical outcomes and streamline operations, ultimately helping women prepare for childbirth and their parenting journeys.

Convergent Dental

Series C in 2021
Convergent Dental, Inc. is a dental equipment and technology company based in Needham, Massachusetts, established in 2011. The company specializes in developing Solea, a computer-aided CO2 laser system designed for both hard and soft tissue dental procedures. This innovative system aims to enhance the patient experience during dental surgeries by providing a quieter and more precise cutting mechanism compared to traditional laser systems. Utilizing patented technologies and advanced computer controls, Solea enables dentists to perform procedures more efficiently while minimizing discomfort for patients.

Activ Surgical

Series B in 2021
Activ Surgical Inc. is a digital surgery company based in Boston, Massachusetts, focused on enhancing surgical efficiency, accuracy, and patient outcomes through advanced technology. Founded in 2014, the company has developed a robotic surgery platform that integrates computer vision, artificial intelligence, and robotics to assist surgeons during complex procedures. One of its key products is the Smart Tissue Autonomous Robot (STAR), which aims to revolutionize surgical practices by improving intraoperative decision-making and reducing the risk of unintended surgical complications. The platform is scalable and patent-protected, designed to support surgeons with augmented reality and data-driven insights, ultimately making surgeries safer and more effective.

Huddle Up

Series A in 2021
Huddle Up is a pediatric digital health company dedicated to supporting the growth, development, and mental health of children. Founded in 2015 and based in Madison, Wisconsin, Huddle Up transforms the care experience by emphasizing peer-to-peer interactions and specialty support. The company partners with school districts to promote academic performance and facilitate social-emotional development, while also focusing on community, equity, inclusion, and belonging. Through its personalized, outcome-driven approach, Huddle Up aims to enhance the well-being of children and adolescents, fostering healthier lives.

Genome Medical

Series C in 2021
Genome Medical, Inc. is a genomic medicine delivery company based in South San Francisco, California, established in 2016. It operates a technology platform known as Genome Care Delivery, which connects individuals and healthcare providers with genetic specialists to facilitate virtual genetic consultations. The company focuses on various areas of clinical care, including cancer, cardiovascular health, reproductive health, pediatrics, and pharmacogenomics. By providing expert genetic assessments and personalized clinical action plans, Genome Medical helps patients understand their genetic risks and make informed treatment decisions. Additionally, the company supports healthcare providers in navigating the growing field of genetics, enhancing disease diagnosis, and improving patient care while aiming to reduce overall healthcare costs.

Main Street Health

Funding Round in 2021
Main Street Health is a provider of value-based, care-focused healthcare services aimed at addressing rural wellness concerns. The company's healthcare services are data-driven, and it provides partner clinics with employees, technology, critical access hospitals, community health centers, and possibilities to flourish in the care delivery model, allowing rural residents to receive the high-quality treatment they need.

Cleerly

Series B in 2021
Cleerly is a healthcare company focused on improving the prevention of heart attacks through innovative digital care pathways. It aims to establish a new standard for coronary artery disease by combining advanced clinical science with cutting-edge artificial intelligence. Cleerly's platform offers a non-invasive approach that quantifies and characterizes plaque buildup in coronary arteries, enhancing the understanding of cardiovascular health. By providing actionable clinical insights, the company enables healthcare providers to better identify at-risk patients and implement early treatment strategies. Ultimately, Cleerly's data-driven solutions aspire to deliver significant value to the healthcare system while improving heart health outcomes for individuals susceptible to heart attacks.

Current Health

Series B in 2021
Current Health Limited, founded in 2014 and based in Edinburgh, United Kingdom, specializes in developing wearable healthcare devices that monitor patients' vital signs. These devices are designed to measure key health metrics such as oxygen saturation, respiration rate, pulse rate, temperature, motion, activity, and posture, allowing for the early identification of unwell patients and timely medical intervention. The company also offers a patient monitoring platform that facilitates home-based care by enabling patients to share daily activities, report symptoms, and respond to structured questionnaires for their healthcare providers. By focusing on remote patient management, Current Health aims to reduce healthcare risks and costs while enhancing patient engagement and monitoring. Formerly known as Snap40 Limited, the company rebranded in December 2018 to better reflect its mission.

Carevive Systems

Series C in 2021
Carevive Systems, Inc. is a company that develops a platform designed to enhance cancer care delivery and patient engagement. The platform includes Carevive PROmpt, which serves as a cancer clinical practice and patient engagement software for treatment planning, symptom management, and survivorship care, as well as offering analytics and evidence-based care plans. It also features a Treatment Care Plans engine, which utilizes rules technology for personalized treatment strategies, and a Navigation/Care Coordination module that facilitates patient eligibility tracking and care plan adherence. Additionally, Carevive Systems provides tools for risk stratification, symptom triage, and patient symptom trending, allowing clinicians to monitor patient progress effectively. The company, based in North Miami, Florida, was incorporated in 2013 and rebranded from On Q Health, Inc. in 2015. Through its solutions, Carevive Systems aims to improve clinical outcomes and support oncology practices in adapting to value-based care models.

Diameter Health

Series B in 2020
Diameter Health, Inc. develops innovative software solutions aimed at enhancing data interoperability for healthcare organizations. The company's flagship product, Fusion, facilitates intelligent data exchange by normalizing and cleansing information from certified electronic health records (EHRs), thereby transforming it into clinically relevant data for point-of-care use and analytics. In addition to Fusion, Diameter Health offers various tools, including Data Dashboard, which provides instant data quality ratings and metrics for clinical document accuracy; Quality, which supports certified quality reporting of e-measures; and Payer Edition, designed for generating standard supplemental reporting data. Other offerings include Subscribe, which allows for automatic updates for specific patient populations, and a scalable Hosted Solution. Diameter Health serves a diverse clientele, including government agencies, health information exchanges, payers, healthcare IT vendors, life insurers, and health systems. Founded in 2013, the company operates from its offices in Farmington, Connecticut, and Wellesley, Massachusetts.

Upfront Healthcare Services

Series B in 2020
Upfront Healthcare Services, Inc. is a Chicago-based company that specializes in creating a data analytics platform aimed at enhancing the ambulatory care experience for patients and healthcare providers. Founded in 2015, the company focuses on automating and personalizing care navigation to improve patient engagement and optimize resource allocation within physician practices. Its platform, known as Care Traffic Control, utilizes advanced analytics and personalized content to guide patients to the most appropriate care options, thereby increasing appointment efficiency and improving clinical outcomes. By leveraging a variety of data sources—including demographics, billing, scheduling, claims, and care gaps—Upfront Healthcare Services ensures that patient needs are effectively matched with available healthcare resources.

Xealth

Venture Round in 2020
Xealth Inc. operates a digital health prescribing platform that allows clinicians to integrate, prescribe, and monitor digital health tools directly from electronic health record (EHR) workflows. Founded in 2016 and based in Seattle, Washington, the platform facilitates patient engagement by enabling care teams to order appropriate digital health tools and programs, which can be sent to patients via email or patient portals. In addition to managing digital health prescriptions, the platform supports patient education and offers non-clinical services such as ride shares and food delivery. This comprehensive approach allows clinicians to monitor patient activity and engagement, ultimately enhancing the overall effectiveness of digital health initiatives within healthcare systems.

Activ Surgical

Venture Round in 2020
Activ Surgical Inc. is a digital surgery company based in Boston, Massachusetts, focused on enhancing surgical efficiency, accuracy, and patient outcomes through advanced technology. Founded in 2014, the company has developed a robotic surgery platform that integrates computer vision, artificial intelligence, and robotics to assist surgeons during complex procedures. One of its key products is the Smart Tissue Autonomous Robot (STAR), which aims to revolutionize surgical practices by improving intraoperative decision-making and reducing the risk of unintended surgical complications. The platform is scalable and patent-protected, designed to support surgeons with augmented reality and data-driven insights, ultimately making surgeries safer and more effective.

Genome Medical

Series B in 2020
Genome Medical, Inc. is a genomic medicine delivery company based in South San Francisco, California, established in 2016. It operates a technology platform known as Genome Care Delivery, which connects individuals and healthcare providers with genetic specialists to facilitate virtual genetic consultations. The company focuses on various areas of clinical care, including cancer, cardiovascular health, reproductive health, pediatrics, and pharmacogenomics. By providing expert genetic assessments and personalized clinical action plans, Genome Medical helps patients understand their genetic risks and make informed treatment decisions. Additionally, the company supports healthcare providers in navigating the growing field of genetics, enhancing disease diagnosis, and improving patient care while aiming to reduce overall healthcare costs.

SilverCloud Health

Series B in 2020
SilverCloud Health, founded in 2011 and based in Boston, Massachusetts, specializes in providing evidence-based digital therapies aimed at improving mental wellness. The company offers tailored online therapeutic solutions that address various mental health issues, enhancing overall emotional health. SilverCloud's platform has demonstrated significant success, achieving a three-fold increase in client engagement and a three-fold decrease in program dropout rates compared to leading online therapeutic products. By providing affordable and accessible digital health resources, SilverCloud Health aims to empower users to manage their mental health more effectively.

Carevive Systems

Series C in 2020
Carevive Systems, Inc. is a company that develops a platform designed to enhance cancer care delivery and patient engagement. The platform includes Carevive PROmpt, which serves as a cancer clinical practice and patient engagement software for treatment planning, symptom management, and survivorship care, as well as offering analytics and evidence-based care plans. It also features a Treatment Care Plans engine, which utilizes rules technology for personalized treatment strategies, and a Navigation/Care Coordination module that facilitates patient eligibility tracking and care plan adherence. Additionally, Carevive Systems provides tools for risk stratification, symptom triage, and patient symptom trending, allowing clinicians to monitor patient progress effectively. The company, based in North Miami, Florida, was incorporated in 2013 and rebranded from On Q Health, Inc. in 2015. Through its solutions, Carevive Systems aims to improve clinical outcomes and support oncology practices in adapting to value-based care models.

Socially Determined

Series A in 2019
Socially Determined, Inc. develops a risk intelligence platform focused on social determinants of health (SDOH). Its primary offering, SocialScape, provides insights into social risks through a combination of social risk indices and visualizations derived from diverse data sources. This platform enables organizations, including health plans, providers, life science companies, and government agencies, to understand the dynamics of social risk and implement actionable programs aimed at enhancing health outcomes while reducing costs. Founded in 2017 and headquartered in Washington, D.C., Socially Determined utilizes secure, cloud-based technology to analyze and visualize community and individual SDOH risks, allowing clients to tailor their intervention strategies to address the specific needs of socially and clinically complex patients.

Genome Medical

Series B in 2019
Genome Medical, Inc. is a genomic medicine delivery company based in South San Francisco, California, established in 2016. It operates a technology platform known as Genome Care Delivery, which connects individuals and healthcare providers with genetic specialists to facilitate virtual genetic consultations. The company focuses on various areas of clinical care, including cancer, cardiovascular health, reproductive health, pediatrics, and pharmacogenomics. By providing expert genetic assessments and personalized clinical action plans, Genome Medical helps patients understand their genetic risks and make informed treatment decisions. Additionally, the company supports healthcare providers in navigating the growing field of genetics, enhancing disease diagnosis, and improving patient care while aiming to reduce overall healthcare costs.

Censinet

Series A in 2019
Censinet, Inc. is a healthcare-focused SaaS company that offers a cloud-based platform for managing third-party risk assessments. Founded in 2017 and based in Winchester, Massachusetts, Censinet connects healthcare providers with their vendors, streamlining the process of assessing and managing risks in real time. The platform eliminates the need for inefficient spreadsheets and manual workflows by automating risk assessments and providing continuous insights into vendor profiles. This approach enables healthcare organizations to identify and address potential threats within their vendor ecosystem effectively, enhancing overall cybersecurity and operational efficiency.

Diameter Health

Series A in 2019
Diameter Health, Inc. develops innovative software solutions aimed at enhancing data interoperability for healthcare organizations. The company's flagship product, Fusion, facilitates intelligent data exchange by normalizing and cleansing information from certified electronic health records (EHRs), thereby transforming it into clinically relevant data for point-of-care use and analytics. In addition to Fusion, Diameter Health offers various tools, including Data Dashboard, which provides instant data quality ratings and metrics for clinical document accuracy; Quality, which supports certified quality reporting of e-measures; and Payer Edition, designed for generating standard supplemental reporting data. Other offerings include Subscribe, which allows for automatic updates for specific patient populations, and a scalable Hosted Solution. Diameter Health serves a diverse clientele, including government agencies, health information exchanges, payers, healthcare IT vendors, life insurers, and health systems. Founded in 2013, the company operates from its offices in Farmington, Connecticut, and Wellesley, Massachusetts.

Verata Health (Now Part of Olive)

Series A in 2019
Verata Health, now part of Olive, was established in 2017 and is headquartered in Bloomington, Minnesota, with additional offices in Minneapolis, Boston, and Orlando. The company specializes in developing artificial intelligence-based software solutions aimed at improving the prior authorization process for healthcare providers and payers. Its platform synthesizes clinical documentation and medical necessity rules to provide real-time decision recommendations, thereby streamlining manual tasks and enhancing efficiency. By removing barriers associated with prior authorization, Verata Health's technology enables healthcare providers, private practices, and pharmacies to take control of their revenue cycles, reduce write-offs, and ensure that patients receive timely care. The company has gained trust from health systems and providers across the country for its innovative approach to modernizing the healthcare authorization process.

First Light Diagnostics

Series A in 2019
First Light Diagnostics Inc. specializes in the development of automated medical diagnostic products aimed at detecting microbes responsible for healthcare-associated infections. The company is known for its benchtop MultiPath analyzer, which identifies both resistant and sensitive strains of Staphylococcus aureus, as well as various toxins and viruses, making it suitable for hospital clinical microbiology laboratories. Its products address multiple applications, including the screening of blood, surgical, skin, and gastrointestinal infections. By offering rapid and cost-effective testing solutions, First Light Diagnostics meets the increasing demand for accurate diagnostics, which is essential for reducing hospital infection rates. The company's proprietary MultiPath detection technology combines the efficiency of advanced laboratory tests with affordability and ease of use. Founded in 2006 and based in Chelmsford, Massachusetts, First Light Diagnostics was previously known as First Light Biosciences until its name change in January 2019.

Cyft

Venture Round in 2019
Cyft, Inc. is a Boston-based company that specializes in developing a cloud-based predictive analytics platform aimed at enhancing healthcare management. Founded in 2015, Cyft partners with various healthcare organizations, including providers, health plans, and life sciences companies, to optimize care management for chronic and complex conditions, as well as behavioral health and dual-eligible populations. The platform utilizes advanced machine learning and natural language processing technologies to analyze a wide array of healthcare data, from claims to case management notes. By leveraging this data, Cyft helps Medicaid plans implement tailored interventions that improve both member health outcomes and financial performance. The company combines technological solutions with hands-on support from healthcare experts, enabling clients to integrate effective practices into their existing workflows. This approach has successfully generated over $100 million in cost savings and new revenue for more than 20 healthcare plans, while also enhancing member retention and satisfaction.

MachineMetrics

Series A in 2018
MachineMetrics Inc. specializes in real-time production monitoring software tailored for manufacturing companies across various industries, including aerospace, automotive, and medical devices. Founded in 2014 and based in Northampton, Massachusetts, the company provides an automated cloud solution that collects, analyzes, and visualizes data from machines. Its platform enables real-time visibility into production processes through live dashboards and predictive notifications, allowing workers to address manufacturing issues promptly. By simplifying the integration of IoT technologies on the shop floor, MachineMetrics enhances manufacturing efficiency, reportedly improving productivity by over 20% for its clients. The company's focus on delivering actionable insights helps clients digitize legacy manufacturing processes and increase profitability.

IntelyCare

Series A in 2018
IntelyCare, Inc. is a healthcare staffing company based in Quincy, Massachusetts, founded in 2014. It provides an on-demand staffing platform that connects nursing professionals with post-acute healthcare facilities, enabling them to optimize staffing levels and manage workforce demands effectively. The platform allows nurses and nursing assistants to create their own schedules and select shifts that suit them, fostering a flexible work environment. Utilizing advanced data science and artificial intelligence, IntelyCare automates scheduling and improves the efficiency of filling nursing shifts, achieving rates three times the industry average. The company serves a variety of clients, including home care agencies, assisted living facilities, long-term care establishments, and rehabilitation hospitals, ultimately aiming to reduce burnout among nursing staff and enhance overall productivity. IntelyCare operates as a subsidiary of Leerink Revelation Healthcare Fund II GP, LLC.

Sansoro Health

Series B in 2018
Sansoro Health, Inc. is a healthcare technology company based in Minneapolis, Minnesota, that specializes in software solutions for electronic medical record (EMR) integration. Its primary product, Emissary, facilitates interoperability between various EMR systems by utilizing universal application programming interfaces (APIs) and a unified data model. Emissary allows for the integrated display of patient charts from multiple EMRs, offering real-time clinical analytics, as well as web and mobile application support. The software can be implemented quickly, often within hours, and is designed to connect with a wide range of third-party software and hardware, significantly reducing costs and complications for healthcare systems. Founded in 2014 and originally known as Sansoro Health, LLC, the company transitioned to its current name in July 2016 and operates as a subsidiary of Datica Health, Inc.

Oculus Health

Series A in 2017
Oculus Health, Inc. operates a chronic care management platform that connects healthcare providers with patients and caregivers. Founded in 2014 and based in Irving, Texas, the company offers a range of services including access to personalized care plans, online and phone support from medical assistants, and real-time health data monitoring. Its platform integrates information from various healthcare sources, such as hospitals and laboratories, to facilitate seamless communication among care teams. Oculus Health also provides tools for remote monitoring, health record management, and patient engagement, aimed at improving patient outcomes and care adherence. By empowering individuals to manage their health proactively, the company seeks to enhance the overall experience of both patients and healthcare providers in a rapidly evolving healthcare landscape.

MachineMetrics

Seed Round in 2016
MachineMetrics Inc. specializes in real-time production monitoring software tailored for manufacturing companies across various industries, including aerospace, automotive, and medical devices. Founded in 2014 and based in Northampton, Massachusetts, the company provides an automated cloud solution that collects, analyzes, and visualizes data from machines. Its platform enables real-time visibility into production processes through live dashboards and predictive notifications, allowing workers to address manufacturing issues promptly. By simplifying the integration of IoT technologies on the shop floor, MachineMetrics enhances manufacturing efficiency, reportedly improving productivity by over 20% for its clients. The company's focus on delivering actionable insights helps clients digitize legacy manufacturing processes and increase profitability.

Connotate

Series B in 2016
Connotate Technologies, Inc., established in 2000 and headquartered in Los Gatos, California, specializes in web data extraction. It offers a platform that transforms web data and content into valuable information assets, serving a wide range of industries including financial information providers, market research companies, and government customers. Connotate's patented intelligent Agent technology enables both business users and programmers to efficiently create data sets, applications, and content products, leading to increased productivity, reduced costs, and improved decision-making. The company operates as a subsidiary of Import.io Ltd.

Carevive Systems

Series B in 2016
Carevive Systems, Inc. is a company that develops a platform designed to enhance cancer care delivery and patient engagement. The platform includes Carevive PROmpt, which serves as a cancer clinical practice and patient engagement software for treatment planning, symptom management, and survivorship care, as well as offering analytics and evidence-based care plans. It also features a Treatment Care Plans engine, which utilizes rules technology for personalized treatment strategies, and a Navigation/Care Coordination module that facilitates patient eligibility tracking and care plan adherence. Additionally, Carevive Systems provides tools for risk stratification, symptom triage, and patient symptom trending, allowing clinicians to monitor patient progress effectively. The company, based in North Miami, Florida, was incorporated in 2013 and rebranded from On Q Health, Inc. in 2015. Through its solutions, Carevive Systems aims to improve clinical outcomes and support oncology practices in adapting to value-based care models.

Medcrypt

Seed Round in 2016
MedCrypt Inc. is a cybersecurity company specializing in the protection of medical devices. Founded in 2016 and based in Encinitas, California, MedCrypt provides data security solutions for a wide range of medical devices, including implantable devices like pacemakers and various surgical robots. The company's platform offers data security as a service to medical device original equipment manufacturers (OEMs), enabling them to implement essential security features quickly and efficiently. These features include user authentication, data encryption, and transaction monitoring to detect potential malicious behavior. By integrating security capabilities into medical devices with minimal code, MedCrypt allows engineers to focus on developing innovative clinical functionalities while ensuring the safety and integrity of device operations.

Diameter Health

Series A in 2016
Diameter Health, Inc. develops innovative software solutions aimed at enhancing data interoperability for healthcare organizations. The company's flagship product, Fusion, facilitates intelligent data exchange by normalizing and cleansing information from certified electronic health records (EHRs), thereby transforming it into clinically relevant data for point-of-care use and analytics. In addition to Fusion, Diameter Health offers various tools, including Data Dashboard, which provides instant data quality ratings and metrics for clinical document accuracy; Quality, which supports certified quality reporting of e-measures; and Payer Edition, designed for generating standard supplemental reporting data. Other offerings include Subscribe, which allows for automatic updates for specific patient populations, and a scalable Hosted Solution. Diameter Health serves a diverse clientele, including government agencies, health information exchanges, payers, healthcare IT vendors, life insurers, and health systems. Founded in 2013, the company operates from its offices in Farmington, Connecticut, and Wellesley, Massachusetts.

lifeIMAGE

Series D in 2015
LifeIMAGE is an online network that enables individuals to exchange medical images. LifeIMAGE is interoperable with the hospital EMR to provide integrated access to medical images, from anywhere. Clinicians can exchange medical images with patients and providers, anywhere. It was founded in 2008 and headquartered in Newton, Massachusetts.

MachineMetrics

Venture Round in 2015
MachineMetrics Inc. specializes in real-time production monitoring software tailored for manufacturing companies across various industries, including aerospace, automotive, and medical devices. Founded in 2014 and based in Northampton, Massachusetts, the company provides an automated cloud solution that collects, analyzes, and visualizes data from machines. Its platform enables real-time visibility into production processes through live dashboards and predictive notifications, allowing workers to address manufacturing issues promptly. By simplifying the integration of IoT technologies on the shop floor, MachineMetrics enhances manufacturing efficiency, reportedly improving productivity by over 20% for its clients. The company's focus on delivering actionable insights helps clients digitize legacy manufacturing processes and increase profitability.

lifeIMAGE

Venture Round in 2015
LifeIMAGE is an online network that enables individuals to exchange medical images. LifeIMAGE is interoperable with the hospital EMR to provide integrated access to medical images, from anywhere. Clinicians can exchange medical images with patients and providers, anywhere. It was founded in 2008 and headquartered in Newton, Massachusetts.

Convergent Dental

Venture Round in 2015
Convergent Dental, Inc. is a dental equipment and technology company based in Needham, Massachusetts, established in 2011. The company specializes in developing Solea, a computer-aided CO2 laser system designed for both hard and soft tissue dental procedures. This innovative system aims to enhance the patient experience during dental surgeries by providing a quieter and more precise cutting mechanism compared to traditional laser systems. Utilizing patented technologies and advanced computer controls, Solea enables dentists to perform procedures more efficiently while minimizing discomfort for patients.

Convergent Dental

Venture Round in 2014
Convergent Dental, Inc. is a dental equipment and technology company based in Needham, Massachusetts, established in 2011. The company specializes in developing Solea, a computer-aided CO2 laser system designed for both hard and soft tissue dental procedures. This innovative system aims to enhance the patient experience during dental surgeries by providing a quieter and more precise cutting mechanism compared to traditional laser systems. Utilizing patented technologies and advanced computer controls, Solea enables dentists to perform procedures more efficiently while minimizing discomfort for patients.

lifeIMAGE

Series B in 2011
LifeIMAGE is an online network that enables individuals to exchange medical images. LifeIMAGE is interoperable with the hospital EMR to provide integrated access to medical images, from anywhere. Clinicians can exchange medical images with patients and providers, anywhere. It was founded in 2008 and headquartered in Newton, Massachusetts.

Phreesia

Series D in 2010
Phreesia is a privately held company that provides innovative software solutions aimed at enhancing patient check-in and engagement in healthcare settings. By replacing traditional patient clipboards with a wireless touchscreen device known as the PhreesiaPad, the company automates the check-in process, securely collecting personal health information in compliance with HIPAA regulations. This technology integrates seamlessly with existing electronic medical records, ensuring that physician workflows are not disrupted while capturing comprehensive patient data. Phreesia also improves the patient experience by facilitating appointment preparation, offering relevant health education, and enabling patients to verify previously recorded information. Additionally, the company focuses on activating patients in their care to optimize health outcomes through a range of services, including registration, appointment scheduling, payment processing, and post-appointment surveys. Backed by premier venture capital firms, Phreesia has raised significant funding to support its mission of enhancing the operational and financial performance of healthcare organizations.

MedVentive

Series C in 2010
MedVentive specializes in technology solutions that enhance the quality and cost-effectiveness of healthcare delivery. Founded by physicians in 1997, the company focuses on providing intervention and information solutions for healthcare delivery networks, payers, and employer coalitions. Its offerings include quality management, registries, pharmacy management, clinical integration, and managed care performance. Additionally, MedVentive provides point-of-care decision support and a pay-for-performance solution that calculates and tracks clinical measures, delivering tailored intervention recommendations for patients. Through these innovative tools, MedVentive aims to facilitate meaningful improvements in healthcare outcomes and reduce overall costs.

Extreme Reach

Series B in 2010
Extreme Reach specializes in content production and creative asset management within the media, entertainment, and advertising sectors. The company offers a comprehensive platform that addresses challenges related to content proliferation and audience fragmentation, providing services such as creative asset management, talent and rights management, and payment solutions. Its flagship product, AdBridge™, streamlines the complex workflows necessary for modern advertising, integrating various processes to enhance campaign execution. With over 200,000 users and managing nearly four million creative assets, Extreme Reach supports leading brands, studios, agencies, and performers by simplifying operational tasks. Additionally, the company is recognized as a leader in commercial talent and rights management and plays a significant role in payroll services for the industry, processing approximately $2 billion annually. By continually innovating its platform, Extreme Reach enables clients to adapt and thrive in an evolving marketplace.

Phreesia

Series D in 2010
Phreesia is a privately held company that provides innovative software solutions aimed at enhancing patient check-in and engagement in healthcare settings. By replacing traditional patient clipboards with a wireless touchscreen device known as the PhreesiaPad, the company automates the check-in process, securely collecting personal health information in compliance with HIPAA regulations. This technology integrates seamlessly with existing electronic medical records, ensuring that physician workflows are not disrupted while capturing comprehensive patient data. Phreesia also improves the patient experience by facilitating appointment preparation, offering relevant health education, and enabling patients to verify previously recorded information. Additionally, the company focuses on activating patients in their care to optimize health outcomes through a range of services, including registration, appointment scheduling, payment processing, and post-appointment surveys. Backed by premier venture capital firms, Phreesia has raised significant funding to support its mission of enhancing the operational and financial performance of healthcare organizations.

Solais Lighting

Series A in 2010
Solais Lighting is a manufacturing company specializing in energy-efficient LED lighting solutions aimed at enhancing various environments, including retail, supermarkets, commercial spaces, museums, and hospitality venues. As a leader in LED lamp technology, Solais focuses on innovation to meet market demands, utilizing advanced techniques such as active cooling to prolong the lifespan and performance of its products while maintaining aesthetic appeal. The company benefits from a skilled executive team with extensive experience across the lighting industry, encompassing research, product development, and manufacturing. With strong financial backing, Solais is well-positioned to grow and adapt to evolving market needs while leveraging a global manufacturing partner to ensure quality and responsiveness in its operations.

GateRocket

Series A in 2009
GateRocket, Inc. provides verification and debugging solutions for FPGAs. It offers RocketDrive, a device native verification system for complex FPGAs, which accelerates verification throughput and identifies problems with IP blocks, pin-outs, and tool chain anomalies. The company also provides RocketVision, a FPGA debug solution that automates test point insertion and detects differences between RTL and FPGA devices. The company was incorporated in 2003 and is headquartered in Bedford, Massachusetts.

lifeIMAGE

Series A in 2009
LifeIMAGE is an online network that enables individuals to exchange medical images. LifeIMAGE is interoperable with the hospital EMR to provide integrated access to medical images, from anywhere. Clinicians can exchange medical images with patients and providers, anywhere. It was founded in 2008 and headquartered in Newton, Massachusetts.

Health Guru Media

Series C in 2009
Healthguru.com is the destination site for health video on the web with 99 million views per month (comScore Video Metrix, August). Our unique approach to health education was developed specifically for the video audience and is differentiated in three key ways: - Category Focus: Healthguru.com focuses on the health topics that matter most to today's audience, including: diet and fitness, mental & emotional health, sexual health, pregnancy, baby health, drugs & alcohol, as well as information on more than 125 different health conditions. - Medium: The modern health consumer seeks out an immersive, rich media experience on the web, and video has proven to be a more engaging medium. Healthguru.com has the largest health video library online, and interactive applications to offer our audience the experience it expects. - Editorial Approach: World-class information providers know that creating truly engaging content is the way to ensure that information becomes learning. That's why Healthguru.com is dedicated to making our content as interesting and, when relevant, entertaining, as it is useful. All Healthguru.com content is created or selected by our editorial team and is rigorously reviewed for medical accuracy, objectivity and balance. While we do accept advertising on our site and may distribute content via third party sites, Healthguru.com does not endorse products, services or companies.

MedVentive

Series C in 2009
MedVentive specializes in technology solutions that enhance the quality and cost-effectiveness of healthcare delivery. Founded by physicians in 1997, the company focuses on providing intervention and information solutions for healthcare delivery networks, payers, and employer coalitions. Its offerings include quality management, registries, pharmacy management, clinical integration, and managed care performance. Additionally, MedVentive provides point-of-care decision support and a pay-for-performance solution that calculates and tracks clinical measures, delivering tailored intervention recommendations for patients. Through these innovative tools, MedVentive aims to facilitate meaningful improvements in healthcare outcomes and reduce overall costs.

Phreesia

Series C in 2009
Phreesia is a privately held company that provides innovative software solutions aimed at enhancing patient check-in and engagement in healthcare settings. By replacing traditional patient clipboards with a wireless touchscreen device known as the PhreesiaPad, the company automates the check-in process, securely collecting personal health information in compliance with HIPAA regulations. This technology integrates seamlessly with existing electronic medical records, ensuring that physician workflows are not disrupted while capturing comprehensive patient data. Phreesia also improves the patient experience by facilitating appointment preparation, offering relevant health education, and enabling patients to verify previously recorded information. Additionally, the company focuses on activating patients in their care to optimize health outcomes through a range of services, including registration, appointment scheduling, payment processing, and post-appointment surveys. Backed by premier venture capital firms, Phreesia has raised significant funding to support its mission of enhancing the operational and financial performance of healthcare organizations.

Extreme Reach

Series A in 2009
Extreme Reach specializes in content production and creative asset management within the media, entertainment, and advertising sectors. The company offers a comprehensive platform that addresses challenges related to content proliferation and audience fragmentation, providing services such as creative asset management, talent and rights management, and payment solutions. Its flagship product, AdBridge™, streamlines the complex workflows necessary for modern advertising, integrating various processes to enhance campaign execution. With over 200,000 users and managing nearly four million creative assets, Extreme Reach supports leading brands, studios, agencies, and performers by simplifying operational tasks. Additionally, the company is recognized as a leader in commercial talent and rights management and plays a significant role in payroll services for the industry, processing approximately $2 billion annually. By continually innovating its platform, Extreme Reach enables clients to adapt and thrive in an evolving marketplace.

Qteros

Series B in 2008
Qteros, Inc. is a biofuels company based in Amherst, Massachusetts, specializing in the development of cellulosic ethanol for transportation fuel. Founded in 1996 and formerly known as SunEthanol, the company focuses on innovative biomass-to-ethanol conversion processes. Central to its technology is the Q Microbe, a naturally occurring microorganism that efficiently converts various nonfood biomass materials, such as trees and plants, into ethanol. By combining enzymatic hydrolysis and fermentation, Qteros aims to provide a cleaner, sustainable alternative to traditional fuels. The company's approach is designed to be simple and environmentally friendly, with the potential for carbon-neutral production. As Qteros advances its technology toward commercial application, it seeks to deliver locally produced transportation fuels that are not only cost-effective but also sustainable.

GateRocket

Series A in 2008
GateRocket, Inc. provides verification and debugging solutions for FPGAs. It offers RocketDrive, a device native verification system for complex FPGAs, which accelerates verification throughput and identifies problems with IP blocks, pin-outs, and tool chain anomalies. The company also provides RocketVision, a FPGA debug solution that automates test point insertion and detects differences between RTL and FPGA devices. The company was incorporated in 2003 and is headquartered in Bedford, Massachusetts.

MedVentive

Series B in 2008
MedVentive specializes in technology solutions that enhance the quality and cost-effectiveness of healthcare delivery. Founded by physicians in 1997, the company focuses on providing intervention and information solutions for healthcare delivery networks, payers, and employer coalitions. Its offerings include quality management, registries, pharmacy management, clinical integration, and managed care performance. Additionally, MedVentive provides point-of-care decision support and a pay-for-performance solution that calculates and tracks clinical measures, delivering tailored intervention recommendations for patients. Through these innovative tools, MedVentive aims to facilitate meaningful improvements in healthcare outcomes and reduce overall costs.

Phreesia

Series B in 2007
Phreesia is a privately held company that provides innovative software solutions aimed at enhancing patient check-in and engagement in healthcare settings. By replacing traditional patient clipboards with a wireless touchscreen device known as the PhreesiaPad, the company automates the check-in process, securely collecting personal health information in compliance with HIPAA regulations. This technology integrates seamlessly with existing electronic medical records, ensuring that physician workflows are not disrupted while capturing comprehensive patient data. Phreesia also improves the patient experience by facilitating appointment preparation, offering relevant health education, and enabling patients to verify previously recorded information. Additionally, the company focuses on activating patients in their care to optimize health outcomes through a range of services, including registration, appointment scheduling, payment processing, and post-appointment surveys. Backed by premier venture capital firms, Phreesia has raised significant funding to support its mission of enhancing the operational and financial performance of healthcare organizations.

Qteros

Series A in 2007
Qteros, Inc. is a biofuels company based in Amherst, Massachusetts, specializing in the development of cellulosic ethanol for transportation fuel. Founded in 1996 and formerly known as SunEthanol, the company focuses on innovative biomass-to-ethanol conversion processes. Central to its technology is the Q Microbe, a naturally occurring microorganism that efficiently converts various nonfood biomass materials, such as trees and plants, into ethanol. By combining enzymatic hydrolysis and fermentation, Qteros aims to provide a cleaner, sustainable alternative to traditional fuels. The company's approach is designed to be simple and environmentally friendly, with the potential for carbon-neutral production. As Qteros advances its technology toward commercial application, it seeks to deliver locally produced transportation fuels that are not only cost-effective but also sustainable.

Phreesia

Series A in 2006
Phreesia is a privately held company that provides innovative software solutions aimed at enhancing patient check-in and engagement in healthcare settings. By replacing traditional patient clipboards with a wireless touchscreen device known as the PhreesiaPad, the company automates the check-in process, securely collecting personal health information in compliance with HIPAA regulations. This technology integrates seamlessly with existing electronic medical records, ensuring that physician workflows are not disrupted while capturing comprehensive patient data. Phreesia also improves the patient experience by facilitating appointment preparation, offering relevant health education, and enabling patients to verify previously recorded information. Additionally, the company focuses on activating patients in their care to optimize health outcomes through a range of services, including registration, appointment scheduling, payment processing, and post-appointment surveys. Backed by premier venture capital firms, Phreesia has raised significant funding to support its mission of enhancing the operational and financial performance of healthcare organizations.

MedVentive

Series A in 2006
MedVentive specializes in technology solutions that enhance the quality and cost-effectiveness of healthcare delivery. Founded by physicians in 1997, the company focuses on providing intervention and information solutions for healthcare delivery networks, payers, and employer coalitions. Its offerings include quality management, registries, pharmacy management, clinical integration, and managed care performance. Additionally, MedVentive provides point-of-care decision support and a pay-for-performance solution that calculates and tracks clinical measures, delivering tailored intervention recommendations for patients. Through these innovative tools, MedVentive aims to facilitate meaningful improvements in healthcare outcomes and reduce overall costs.

Optasite

Series B in 2005
Optasite engages in the acquisition and development of telecommunications tower sites in the United States. It offers wireless consulting services. The company's services also include site leasing and colocation, tower acquisition, and site development. It serves broadband wireless providers, including wireless carriers, as well as other customers in the telecommunications industry, such as the FCC licensed carriers, government agencies, public safety organizations, private enterprises, and two-way radio services. Optasite, Inc. was formerly known as Pinnacle Site Development, Inc

GetWellNetwork

Series B in 2005
GetWellNetwork, Inc. is a Bethesda, Maryland-based company that specializes in developing precision engagement software solutions aimed at enhancing patient involvement in the healthcare process. Founded in 1999 by Michael O’Neil Jr., the company provides a range of interactive tools tailored for hospitals, including the GetWell Patient Care solution, which integrates various resources to activate patient participation. Its offerings encompass digital check-in systems, entertainment options, and personalized education through a library of condition-specific content. The GetWellNetwork platform utilizes predefined workflows, known as Patient Pathways, to deliver educational materials and engage patients in their care journey. This approach facilitates real-time monitoring and documentation of patient progress, enabling healthcare providers to customize experiences based on individual needs. GetWellNetwork primarily serves healthcare providers, pediatric hospitals, and government organizations, striving to improve patient care outcomes through enhanced engagement and education.

Verax Biomedical

Series B in 2005
Verax Biomedical, Incorporated is a medical products company focused on developing rapid tests for detecting bacterial contamination in blood cells and tissues intended for transplantation and cellular therapies. Founded in 1999 and based in Marlborough, Massachusetts, the company addresses a critical need in the field of transfusion medicine, as traditional testing primarily targets viral contaminants, leaving bacterial risks largely unaddressed. Bacteria can proliferate in stored cellular materials, potentially growing from negligible levels at the time of collection to dangerous levels by the time of transfusion or transplantation. Verax Biomedical’s offerings include platelet and red cell Pan Genera Detection tests, designed to identify shared antigens found on various gram-positive and gram-negative bacteria. These tests enable blood banks to effectively detect and mitigate the risks associated with bacterial contamination, thereby enhancing the safety of blood transfusions and cellular therapies.

Aircuity

Series C in 2005
Aircuity, Inc. specializes in intelligent measurement solutions aimed at enhancing energy efficiency and indoor environmental quality in various settings, including commercial offices, educational institutions, healthcare facilities, and public venues. The company offers a range of products, including the Sensor Suite, which supports multipoint environmental sampling, and various sensors and probes designed for specific monitoring tasks, such as temperature and air quality. Their technology enables demand-controlled ventilation, allowing buildings to optimize energy use while maintaining safe and comfortable environments. Founded in 2000 and headquartered in Newton, Massachusetts, Aircuity markets its solutions across multiple international regions, reinforcing its commitment to improving indoor air quality and operational efficiency.

Aircuity

Series C in 2004
Aircuity, Inc. specializes in intelligent measurement solutions aimed at enhancing energy efficiency and indoor environmental quality in various settings, including commercial offices, educational institutions, healthcare facilities, and public venues. The company offers a range of products, including the Sensor Suite, which supports multipoint environmental sampling, and various sensors and probes designed for specific monitoring tasks, such as temperature and air quality. Their technology enables demand-controlled ventilation, allowing buildings to optimize energy use while maintaining safe and comfortable environments. Founded in 2000 and headquartered in Newton, Massachusetts, Aircuity markets its solutions across multiple international regions, reinforcing its commitment to improving indoor air quality and operational efficiency.

Optasite

Series A in 2004
Optasite engages in the acquisition and development of telecommunications tower sites in the United States. It offers wireless consulting services. The company's services also include site leasing and colocation, tower acquisition, and site development. It serves broadband wireless providers, including wireless carriers, as well as other customers in the telecommunications industry, such as the FCC licensed carriers, government agencies, public safety organizations, private enterprises, and two-way radio services. Optasite, Inc. was formerly known as Pinnacle Site Development, Inc

Medical Metrx Solutions

Series B in 2003
Medical Metrx Solutions, Inc. (formerly Medical Media Systems) is a medical technology and services company providing diagnostic quality 3-D virtual models of patient anatomy built from CT and MR scan data using the company’s proprietary modeling software. The company’s models — which contain more precise quantitative measurement information than competitors’ offerings — are provided to interventional radiologists and vascular surgeons who use them for pre-operative planning and post-operative surveillance of their patients’ conditions. The company was acquired by AIG Altaris Health Partners in 2005.

Protedyne

Venture Round in 2001
Protedyne is a developer of laboratory automation systems, focusing on the pharmaceutical and biotech industries. As a wholly owned subsidiary of Laboratory Corporation of America since May 2007, Protedyne integrates industrial automation principles into diagnostic testing facilities nationwide. The company designs advanced robotic systems characterized by an enclosed platform featuring a 4-axis robotic arm, which enhances workflow efficiency by providing versatility in deck capacity and configuration options. Protedyne's automation systems are engineered to improve data management and process tracking, ensuring effective laboratory operations. The company is ISO 13485:2003 Registered with BSI Management Systems, underscoring its commitment to quality and compliance in its automation technologies.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.